For its Walmart’s Medical Clinics report, Reaction Data interviewed 132 individuals from healthcare provider organizations across the U.S. about their opinions on Walmart’s strategy. The report participants included executives such as CEOs, CNOs and COOs as well as clinicians.
Of those surveyed, 30 percent are convinced that Walmart’s freestanding health center model will pose a negative impact on traditional providers, while 27 percent said it will have no impact. Twenty-five percent of participants indicated Walmart’s medical clinics will have a positive impact on other providers, and 18 percent said they were unsure what implications will arise.
When asked what other companies might follow Walmart’s lead, participants listed the following:
Other: 21 percent
Target: 20 percent
Amazon: 19 percent
Walgreens: 15 percent
CVS: 14 percent
Apple: 8 percent
Costco: 3 percent
Rite Aid: 2 percent
Hy-Vee: 2 percent
Google: 2 percent
To access the full report, click here.
More articles on strategy:
Walmart expands standalone health center model
What’s next for the Camden Coalition after MIT study challenges core strategy
‘Cluster hiring’ could completely change how executive teams are formed
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
